Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-21-031376

EVP and Chief Medical Officer sold 364 shares at $113.67 ($41,376)

From the SEC's structured data for this filing

Trades in this filing

Bedrosian Camille L · EVP and Chief Medical Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-06 Sale : show line 1 in the form −364 $113.67 $41,376 38,775 D
Open-market sales · 364 sh · avg $113.67 · $41,376
Loading xslF345X03/doc4.xml…